Cervical metastases of occult origin: the impact of combined modality therapy
- PMID: 7977958
- DOI: 10.1016/s0002-9610(05)80083-2
Cervical metastases of occult origin: the impact of combined modality therapy
Abstract
Background: We have updated our experience with metastatic carcinoma to the neck of occult origin to assess whether increasing use of adjunctive radiation therapy has had a significant impact.
Methods: This retrospective review of 115 patients treated between 1977 and 1990 includes 73 (63%) with squamous cell carcinoma. These 73 patients were analyzed for survival, control of disease in the neck, and incidence of subsequent primary tumors.
Results: There has been no change in the proportion of patients with advanced neck disease (N2/N3 = 52; 71%) when compared to our last report. Surgery included comprehensive neck dissection in 59 (81%) and adjunctive radiotherapy was employed in 54 (83% of surgically treated patients). Primary carcinomas within the head and neck were identified subsequently in 9 (12%) patients, including 4 of 11 (36%) who did not have adjunctive radiotherapy and 5 of 54 (9%) who did (P = 0.038). Control of the treated neck (54/73; 74%) has improved significantly (P = 0.005) when compared to our earlier experience (37/74; 50%), and this was most apparent in those with extensive neck disease. However, cumulative survival at 5 years (45%) was not significantly different from that previously reported.
Conclusion: Our data support the increased use of adjunctive radiation therapy for metastatic squamous cell carcinoma in the neck of occult origin. Control of neck disease has improved and the likelihood that a primary will be identified has been reduced, but there has been no improvement in survival when compared to historical controls.
Similar articles
-
Neck dissection and ipsilateral radiotherapy in the management of cervical metastatic carcinoma from an unknown primary.Aust N Z J Surg. 2000 Apr;70(4):263-8. doi: 10.1046/j.1440-1622.2000.01804.x. Aust N Z J Surg. 2000. PMID: 10779057
-
Cervical lymph node metastases from occult squamous cell carcinoma: analysis of 82 cases.ORL J Otorhinolaryngol Relat Spec. 2006;68(4):189-94. doi: 10.1159/000091394. Epub 2006 Feb 8. ORL J Otorhinolaryngol Relat Spec. 2006. PMID: 16479145
-
Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):346-52. doi: 10.1016/j.ijrobp.2010.06.031. Epub 2010 Oct 8. Int J Radiat Oncol Biol Phys. 2011. PMID: 20933340
-
Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.Cancer Treat Rev. 2004 Apr;30(2):153-64. doi: 10.1016/j.ctrv.2003.10.001. Cancer Treat Rev. 2004. PMID: 15023433 Review.
-
Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature.Strahlenther Onkol. 2005 Jun;181(6):355-62. doi: 10.1007/s00066-005-1338-2. Strahlenther Onkol. 2005. PMID: 15925977 Review.
Cited by
-
Diagnosis and management of neck metastases from an unknown primary.Acta Otorhinolaryngol Ital. 2005 Feb;25(1):2-12. Acta Otorhinolaryngol Ital. 2005. PMID: 16080309 Free PMC article. Review.
-
Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma.Head Neck Pathol. 2008 Sep;2(3):163-8. doi: 10.1007/s12105-008-0066-1. Epub 2008 Jun 24. Head Neck Pathol. 2008. PMID: 20614311 Free PMC article.
-
Cervical lymph node metastases from occult squamous cell carcinoma.Curr Treat Options Oncol. 2002 Feb;3(1):33-40. doi: 10.1007/s11864-002-0039-7. Curr Treat Options Oncol. 2002. PMID: 12057085 Review.
-
Management of cervical metastasis.Curr Oncol Rep. 2004 Mar;6(2):141-51. doi: 10.1007/s11912-004-0026-1. Curr Oncol Rep. 2004. PMID: 14751092 Review.
-
Patterns of Failure in Patients With Head and Neck Squamous Cell Carcinomas of Unknown Primary Treated With Chemoradiotherapy.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820905826. doi: 10.1177/1533033820905826. Technol Cancer Res Treat. 2020. PMID: 32484037 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical